Literature DB >> 20665531

Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.

Chu Zhang1, Mehrnoosh Soori, Fayth L Miles, Robert A Sikes, Daniel D Carson, Leland W K Chung, Mary C Farach-Carson.   

Abstract

BACKGROUND: Preferential bony metastasis of human prostate cancer (PCa) cells contributes to disease mortality and morbidity. Local factors in bone stromal extracellular matrix microenvironment affect tumor growth through paracrine interactions between tumor and stromal cells.
METHODS: Using co-culture and medium transfer, we used several methods to assess interactions between PCa and bone stromal cells using three PCa cell lines: PC3, LNCaP, and the LNCaP derivative, C4-2B.
RESULTS: Co-culture of LNCaP and C4-2B cells with bone marrow stromal cell lines, HS27a and HS5, decreased cell number, as did culture with conditioned medium (CM) harvested from these two cell lines suggesting a soluble paracrine factor was responsible. PC3 cell growth was unaffected. CM harvested from bone stromal cell lines triggered apoptosis in LNCaP and C4-2B cell lines, but not in PC3 cells. Surviving C4-2B cells grown in bone stromal cell CM over several days were growth arrested, suggesting presence of a growth inhibitor. Apoptosis induced by CM was dose-dependent. Flow cytometry demonstrated that over a 5-day culture period in stromal cell CM, LNCaP, and C4-2B cell lines, but not PC3 cells, underwent greater apoptosis than parallel cultures in SF medium. The LNCaP and C4-2B cells showed morphology and biomarker expression consistent with transdifferentiation towards a neuroendocrine phenotype after exposure to stromal cell CM.
CONCLUSIONS: The reactive bone stromal microenvironment initially is hostile to PCa cells producing widespread apoptosis. Activation of transdifferentiation in a subset of apoptotic resistant cells may support phenotypic adaptation during disease progression in bone, eventually favoring lethal disease.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20665531      PMCID: PMC2972389          DOI: 10.1002/pros.21231

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  34 in total

Review 1.  Neuroendocrine differentiation in prostatic carcinoma.

Authors:  P A Abrahamsson
Journal:  Prostate       Date:  1999-05       Impact factor: 4.104

2.  Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a.

Authors:  Lynn Graf; Mineo Iwata; Beverly Torok-Storb
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 3.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Authors:  Leland W K Chung; Adam Baseman; Vasily Assikis; Haiyen E Zhau
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

4.  Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow.

Authors:  S H Lang; W R Miller; F K Habib
Journal:  Prostate       Date:  1995-11       Impact factor: 4.104

5.  Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.

Authors:  Thomas Fixemer; Klaus Remberger; Helmut Bonkhoff
Journal:  Prostate       Date:  2002-10-01       Impact factor: 4.104

Review 6.  Neuroendocrine differentiation in prostatic carcinoma.

Authors:  Jens Hansson; Per-Anders Abrahamsson
Journal:  Scand J Urol Nephrol Suppl       Date:  2003

7.  Bone metastasis: Osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry.

Authors:  Kerstin Knerr; Karin Ackermann; Tanja Neidhart; Walter Pyerin
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

8.  Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes.

Authors:  B A Roecklein; B Torok-Storb
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  Cellular interactions in the tropism of prostate cancer to bone.

Authors:  Robert A Sikes; Brian E Nicholson; Kenneth S Koeneman; N Magnus Edlund; Eric A Bissonette; Michael J Bradley; George N Thalmann; Marco G Cecchini; Kenneth J Pienta; Leland W K Chung
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396

View more
  19 in total

1.  p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.

Authors:  Megan A Chang; Micaela Morgado; Curtis R Warren; Cimona V Hinton; Mary C Farach-Carson; Nikki A Delk
Journal:  Prostate       Date:  2013-09-30       Impact factor: 4.104

2.  Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.

Authors:  Nikki A Delk; Mary C Farach-Carson
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

3.  Neuronal Trans-Differentiation in Prostate Cancer Cells.

Authors:  Andrew Farach; Yi Ding; MinJae Lee; Chad Creighton; Nikki A Delk; Michael Ittmann; Brian Miles; David Rowley; Mary C Farach-Carson; Gustavo E Ayala
Journal:  Prostate       Date:  2016-07-12       Impact factor: 4.104

4.  Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.

Authors:  Daniel W Sherbenou; Blake T Aftab; Yang Su; Christopher R Behrens; Arun Wiita; Aaron C Logan; Diego Acosta-Alvear; Byron C Hann; Peter Walter; Marc A Shuman; Xiaobo Wu; John P Atkinson; Jeffrey L Wolf; Thomas G Martin; Bin Liu
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

5.  SDF-1 induces TNF-mediated apoptosis in cardiac myocytes.

Authors:  Andrew A Jarrah; Martina Schwarskopf; Edward R Wang; Thomas LaRocca; Ashwini Dhume; Shihong Zhang; Lahouria Hadri; Roger J Hajjar; Alison D Schecter; Sima T Tarzami
Journal:  Apoptosis       Date:  2018-01       Impact factor: 4.677

6.  Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells.

Authors:  Shayna E Thomas-Jardin; Mohammed S Kanchwala; Joan Jacob; Sana Merchant; Rachel K Meade; Nagham M Gahnim; Afshan F Nawas; Chao Xing; Nikki A Delk
Journal:  Prostate       Date:  2018-03-11       Impact factor: 4.104

7.  PC3 is a cell line characteristic of prostatic small cell carcinoma.

Authors:  Sheng Tai; Yin Sun; Jill M Squires; Hong Zhang; William K Oh; Chao-Zhao Liang; Jiaoti Huang
Journal:  Prostate       Date:  2011-03-22       Impact factor: 4.104

8.  Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.

Authors:  Daniel W Sherbenou; Yang Su; Christopher R Behrens; Blake T Aftab; Olivia Perez de Acha; Megan Murnane; Shelby C Bearrows; Byron C Hann; Jeffery L Wolf; Thomas G Martin; Bin Liu
Journal:  Clin Cancer Res       Date:  2020-09-11       Impact factor: 12.531

9.  IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells.

Authors:  M A Chang; V Patel; M Gwede; M Morgado; K Tomasevich; E L Fong; M C Farach-Carson; Nikki A Delk
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

10.  Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways.

Authors:  Lili Liu; Zhiying Xu; Binbin Yu; Li Tao; Ying Cao
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.